Kari Alitalo
- Oncology top 0.01%
- Lymphatic System and Diseases 283
- Vascular Tumors and Angiosarcomas 48
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism 43
- Molecular Biology top 0.01%
- Angiogenesis and VEGF in Cancer 320
- Immunology and Allergy top 0.02%
- Cell Adhesion Molecules Research 57
- Cell Biology top 0.02%
-
- Sympathectomy and Hyperhidrosis Treatments 58
-
- Axon Guidance and Neuronal Signaling 51
-
- Vascular Malformations and Hemangiomas 48
- Co-authors
- Tuomas TammelaMichael JeltschSeppo Ylä‐HerttualaMarika J. KarkkainenTaija MäkinenTerhi KärpänenRalf H. AdamsArja Kaipainen
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Kari Alitalo
708 papers receiving 91.7k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Oncology 45.5k
- Cancer Research 12.5k
- Molecular Biology 56.8k
- Immunology and Allergy 4.8k
- Cell Biology 8.6k
Countries citing papers authored by Kari Alitalo
This map shows the geographic impact of Kari Alitalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Alitalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Alitalo more than expected).
Fields of papers citing papers by Kari Alitalo
This network shows the impact of papers produced by Kari Alitalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Alitalo. The network helps show where Kari Alitalo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kari Alitalo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2020 | 66 | |
| 3 | 2020 | 4 | |
| 4 | 2017 | 126 | |
| 5 | 2016 | 32 | |
| 6 | 2015 | 187 | |
| 7 | 2015 | 58 | |
| 8 | 2014 | 178 | |
| 9 | 2013 | 9 | |
| 10 | 2012 | 27 | |
| 11 | 2010 | 139 | |
| 12 | 2010 | 44 | |
| 13 | 2009 | 44 | |
| 14 | 2008 | 131 | |
| 15 | 2008 | 294 | |
| 16 | 2008 | 107 | |
| 17 | 2007 | 184 | |
| 18 | 2005 | 124 | |
| 19 | 2004 | 71 | |
| 20 | VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiabreakdown → | 2003 | 2147 |
About Kari Alitalo
Kari Alitalo is a scholar working on Oncology, Immunology and Allergy and Molecular Biology, having authored 716 papers that have together received 94.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (320 papers), Lymphatic System and Diseases (283 papers), Sympathectomy and Hyperhidrosis Treatments (58 papers), Cell Adhesion Molecules Research (57 papers), Axon Guidance and Neuronal Signaling (51 papers), Vascular Tumors and Angiosarcomas (48 papers), Vascular Malformations and Hemangiomas (48 papers) and Cancer, Hypoxia, and Metabolism (43 papers). The work is most often cited by research in Oncology (45.5k citations), Cancer Research (12.5k citations) and Molecular Biology (56.8k citations). Kari Alitalo has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Tuomas Tammela, Michael Jeltsch, Seppo Ylä‐Herttuala, Marika J. Karkkainen, Taija Mäkinen, Terhi Kärpänen, Ralf H. Adams, Arja Kaipainen, Tatiana V. Petrova and Vladimir Joukov. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.